COST-EFFECTIVENESS OF VARIOUS COMBINATIONS OF HUMAN PAPILLOMAVIRUS (HPV)-BASED PRIMARY SCREENING TESTING, INCLUDING GENOTYPING FOR HPV 16/18, FOR CERVICAL CANCER SCREENING IN MEXICO

被引：0
|
作者：
Corro, A. [1 ]
Ramirez, A. [1 ]
Williams, E. [2 ]
Huang, J. [3 ]
Souza, F. H. [4 ]
机构：
[1] Roche Diagnost, Mexico City, DF, Mexico
[2] Xcenda, Palm Harbor, FL USA
[3] Roche Mol Diagnost, Pleasanton, CA USA
[4] Roche Diagnost, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1947
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A671 / A671
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF VARIOUS COMBINATIONS OF HUMAN PAPILLOMAVIRUS (HPV)-BASED TESTING, INCLUDING GENOTYPING FOR HPV 16/18, FOR CERVICAL CANCER SCREENING
    Huh, W.
    Williams, E.
    Bramley, T.
    Huang, J.
    Poulios, N.
    VALUE IN HEALTH, 2013, 16 (03) : A142 - A143
  • [2] Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
    Goldhaber-Fiebert, Jeremy D.
    Stout, Natasha K.
    Salomon, Joshua A.
    Kuntz, Karen M.
    Goldie, Sue J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (05): : 308 - 320
  • [3] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    PLOS ONE, 2015, 10 (03):
  • [4] Re: Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
    Giorgi Rossi, Paolo
    Zappa, Marco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (22): : 1654 - 1654
  • [5] Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial
    Cromwell, Ian
    Smith, Laurie W.
    van der Hoek, Kim
    Hedden, Lindsay
    Coldman, Andrew J.
    Cook, Darrel
    Franco, Eduardo L.
    Krajden, Mel
    Martin, Ruth
    Lee, Marette H.
    Stuart, Gavin
    van Niekerk, Dirk
    Ogilvie, Gina
    Peacock, Stuart
    CANCER MEDICINE, 2021, 10 (09): : 2996 - 3003
  • [6] Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
    Warner K. Huh
    Erin Williams
    Joice Huang
    Tommy Bramley
    Nick Poulios
    Applied Health Economics and Health Policy, 2015, 13 : 95 - 107
  • [7] Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
    Huh, Warner K.
    Williams, Erin
    Huang, Joice
    Bramley, Tommy
    Poulios, Nick
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2015, 13 (01) : 95 - 107
  • [8] HPV16 and HPV18 genotyping in cervical cancer screening
    Ronco, Guglielmo
    Franceschi, Silvia
    Segnan, Nereo
    LANCET ONCOLOGY, 2011, 12 (09): : 831 - 832
  • [9] Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico
    Torres-Ibarra, Leticia
    Cuzick, Jack
    Lorincz, Attila T.
    Spiegelman, Donna
    Lazcano-Ponce, Eduardo
    Franco, Eduardo L.
    Barbara Moscicki, Anna
    Mahmud, Salaheddin M.
    Wheeler, Cosette M.
    Rivera-Paredez, Berenice
    Hernandez-Lopez, Rubi
    Leon-Maldonado, Leith
    Salmeron, Jorge
    Gravitt, Patti
    Schmeler, Kathleen M.
    Castle, Philip E.
    Mendez-Hernandez, Pablo
    Hernandez-Avila, Mauricio
    Ramirez, Paula
    Flores, Yvonne
    Bishai, David
    Mendiola, Indira
    Meneses, Joacim
    Hernandez, Pilar
    Carmona, Enrique
    JAMA NETWORK OPEN, 2019, 2 (11)
  • [10] Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
    Fogelberg, Sara
    Clements, Mark S.
    Pedersen, Kine
    Sy, Stephen
    Sparen, Par
    Kim, Jane J.
    Burger, Emily A.
    PLOS ONE, 2020, 15 (09):
12345